Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20


Category: Technology

April 14, 2021

Codex DNA partners with researchers to discover a new way to control citrus greening disease

The bacterial scourge of the citrus greening disease has affected citrus production worldwide, causing tree decline and a serious threat to Florida’s citrus industry. Citrus greening disease, or Huanglongbing (HLB), is caused by Candidotus liberibacter (CLass) and is spread by…

March 24, 2021

For HIV vaccine study, scientists build pooled variant library using automated DNA synthesis

The quest for an effective vaccine against HIV has spanned decades. While the vaccine itself remains elusive, researchers are making important strides in figuring out how best to design and develop it. Recently, scientists from Duke University and NIH’s Vaccine…

March 17, 2021

Great science: virtual AGBT and ABRF meetings highlight COVID-19 and more

The Codex DNA team loves to get its geek on. For the past year, we’ve missed in-person conferences, but virtual events still let us get up to speed on some of the latest advances in the scientific community. Most recently,…

March 10, 2021

Automated DNA synthesis in the spotlight at SLAS

The Codex DNA team was delighted to participate in this year’s SLAS annual conference, held by the Society for Laboratory Automation and Screening. While our favorite part of the virtual event was getting to interact with the many attendees who…

February 17, 2021

New resource: Biocompare ebook illustrates how life science tools are accelerating COVID-19 research

It can be tough to keep up on the latest COVID-19 news, but a new ebook from Biocompare is here to help. The ebook offers a nice array of articles focused on how novel tools are being used to accelerate…

February 10, 2021

Scientists use Codex DNA technology to discover fever-protective element in malaria parasite

Scientists have made a new discovery that could eventually lead to more effective treatment for malaria. In a series of experiments that included using the BioXp™ system, they determined that a key phospholipid and a related protein confer protection against…

January 27, 2021

AI-powered design tool and BioXp™ system accelerate metabolic engineering

The next industrial revolution will be biological. By turning cells into factories, synthetic biology changes how we make everything from plastic to food to medicine. But achieving those goals will require overcoming the limitations of DNA design. This is still…

January 20, 2021

Targeted mutagenesis could streamline antibody engineering

Monoclonal antibodies represent an important class of therapies for an ever-increasing number of diseases, infections, and health conditions. That’s why scientists around the world are working to improve the processes required to engineer new antibody candidates for therapeutic use. The…

January 13, 2021

Ready-made SARS-CoV-2 genomes from Codex DNA power development of vaccines, therapies, and diagnostics

Since the start of the COVID-19 pandemic, the Codex DNA team has been working hard to ensure that our customers have access to the tools they need to help in the fight against this public health scourge. We currently offer…

December 23, 2020

T cell engineering: How the BioXp™ system boosts productivity and decreases discovery time

At a recent Oxford Global NextGen Omics UK congress, our own Kirsty Maclean gave a presentation about how the BioXp™ system is powering advances in cell engineering. While she started with a high-level view of how synthetic biology applies to…

December 16, 2020

A vaccine printer at your local drugstore? We are making it happen

You probably know Codex DNA as the developer of the world’s first and only automated benchtop solution for generating gene fragments, clones, and libraries. While we’re incredibly proud of what we’ve accomplished so far, our mission goes well beyond streamlining…

December 9, 2020

BioXp™ system chosen as one of the year’s best innovations by The Scientist

There’s celebrating in the halls — and virtual halls — of Codex DNA. We are truly honored that our new BioXp™ 3250 system was selected as one of the year’s best innovations by The Scientist. This is a very prestigious…

December 2, 2020

Cellibre scientists accelerate enzyme engineering with Codex DNA collaboration

One of the most popular applications of synthetic biology is to confer desired traits to an organism. Designing a range of possibilities and then testing each one for fitness, productivity, stability, or some other goal is critically important as the…

November 24, 2020

In pandemics, rapid DNA synthesis accelerates vaccine development

Back in 2013, I played a small role in response to what then seemed like the next potential pandemic — an outbreak of H7N9, an avian influenza virus. At the time, I was working with Novartis scientists, and we were…

November 11, 2020

Scientists develop nanobody treatments with the BioXp™ system

In the age of COVID-19, there has been a ton of scientific interest in nanobodies, or single-domain antibodies that can be used for finely targeted viral vaccines. It’s also been a hot topic among users of our BioXp™ system —…

November 4, 2020

Rapid discovery + development of a monoclonal antibody to combat SARS-CoV-2

Without question, the global outbreak of the novel coronavirus 2019 (SARS-CoV-2) that causes COVID-19 has dominated scientific discussion and has been fodder for a wealth of publications as the world urgently races for a better understanding of the mechanism of…

October 28, 2020

Codex DNA celebrates Breast Cancer Awareness Month with great science

Breast cancer is now recognized as the most common malignancy worldwide among women, irrespective of age. Today’s standard of care and breast cancer management relies heavily on chemotherapy, hormone therapy, and targeted therapy. However, there is still much to be…

October 21, 2020

Highlights from the SynBioBeta 2020 Conference

The Codex DNA team really enjoyed attending this year’s virtual Global Synthetic Biology Conference hosted by SynBioBeta. If you missed the event, we’ve got you covered — here’s our take on highlights from the meeting. BioXp™ system in the spotlight…

September 30, 2020

Accelerating therapeutic discoveries for lymphoma

The treatment landscape for lymphoma – especially aggressive B-cell lymphomas — has been transformed by adoptive cellular immunotherapy with chimeric antigen receptor (CAR) T cells. Clinical trials with a focus on anti-CD19 CAR-T cell therapy have shown efficacy and long-term…

August 26, 2020

Meet the BioXp™ 3250 system, our new automated synthetic biology workstation

Please join us in welcoming the newest member of the Codex DNA family. Like its BioXp™ 3200 predecessor, the BioXp™ 3250 system is a fully automated, benchtop platform for synthetic biology workflows — but this one reduces the timelines for…

Contact us

The expertise of our scientists, engineers, and supporting teams is always available. Or call us: 858.228.4115

By clicking Submit, you agree that Codex DNA may use this information to contact you about our programs, products, or services. You may opt out at any time.

Your personal data is handled according to our privacy policy. In addition, if you are located within a distributor territory, you may be contacted directly by them. We never sell your data to anyone.